Combination therapy with bone marrow stromal cells and FK506 enhanced amelioration of ischemic brain damage in rats

Life Sciences

Volumn 89, Issue 1-2, 2011, Pages 50-56

  Suda, Satoshi ^a,b   Shimazaki, Kuniko ^b   Ueda, Masayuki ^a   Inaba, Toshiki ^a   Kamiya, Nobuo ^a   Katsura, Ken Ichiro ^a   Katayama, Yasuo ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute transplantation; Apoptosis; Cerebral focal ischemia; Inflammation; MSC

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW STROMAL CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; COMBINED MODALITY THERAPY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; STROMAL CELLS; TACROLIMUS; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

EID: 79959345298     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.05.001     Document Type: Article

References (47)

1. Amemiya S, Kamiya T, Nito C, Inaba T, Kato K, Ueda M, et al. Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats. Eur J Pharmacol 2005;516:125-30. (Pubitemid 40799348)
2. Arii T, Kamiya T, Arii K, Ueda M, Nito C, Katsura K, et al. Neuroprotective effect of immunosuppressant FK506 in transient focal ischemia in rat: therapeutic time window for FK506 in transient focal ischemia. Neurol Res 2001;23:755-60. (Pubitemid 32952707)
3. Ay I, Sugimori H, Finklestein SP. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 2001;87:71-80. (Pubitemid 32167042)
4. Azizi SA, Stokes D, Augelli BJ, DiGirolamo C, Prockop DJ. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - similarities to astrocyte grafts. Proc Natl Acad Sci U S A 1998;95:3908-13. (Pubitemid 28173227)
5. Baker AH, Sica V, Work LM, Williams-Ignarro S, de Nigris F, Lerman LO, et al. Brain protection using autologous bone marrow cell, metalloproteinase inhibitors, and metabolic treatment in cerebral ischemia. Proc Natl Acad Sci U S A 2007;104: 3597-602. (Pubitemid 46364204)
6. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-82. (Pubitemid 40798626)
7. Bennett WM. The nephrotoxicity of new and old immunosuppressive drugs. Ren Fail 1998;20:687-90. (Pubitemid 28413225)
8. Borlongan CV, Lind JG, Dillon-Carter O, Yu G, Hadman M, Cheng C, et al. Bone marrow grafts restore cerebral blood flow and blood brain barrier in stroke rats. Brain Res 2004;1010:108-16. (Pubitemid 38569858)
9. Butcher SP, Henshall DC, Teramura Y, Iwasaki K, Sharkey J. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci 1997;17:6939-46. (Pubitemid 27427872)
10. Chen J, Graham SH, Chan PH, Lan J, Zhou RL, Simon RP. Bcl-2 is expressed in neurons that survive focal ischemia in the rat. Neuroreport 1995;6:394-8.
11. Chen J, Li Y, Wang L, Lu M, Chopp M. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J Neurol Sci 2002;199:17-24. (Pubitemid 34669838)
12. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, et al. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 2003;73:778-86. (Pubitemid 37071731)
13. Furuichi Y, Katsuta K, Maeda M, Ueyama N, Moriguchi A, Matsuoka N, et al. Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy. Brain Res 2003;965:137-45. (Pubitemid 36183695)
14. Furuichi Y, Noto T, Li JY, Oku T, Ishiye M, Moriguchi A, et al. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res 2004;1014:120-30. (Pubitemid 38798459)
15. Gold BG, Katoh K, Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J Neurosci 1995;15:7509-16.
16. Guo X, Dawson VL, Dawson TM. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons. Eur J Neurosci 2001;13: 1683-93. (Pubitemid 32488058)
17. Guzman R, De Los Angeles A, Cheshier S, Choi R, Hoang S, Liauw J, et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008;39:1300-6. (Pubitemid 351440705)
18. Ikeda N, Nonoguchi N, Zhao MZ, Watanabe T, Kajimoto Y, Furutama D, et al. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 2005;36:2725-30.
19. Justicia C, Martin A, Rojas S, Gironella M, Cervera A, Panes J, et al. Anti-VCAM-1 antibodies did not protect against ischemic damage either in rats or in mice. J Cereb Blood Flow Metab 2006;26:421-32.
20. Kamiya N, Ueda M, Igarashi H, Nishiyama Y, Suda S, Inaba T, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 2008;83:433-7.
21. Katsura K, Kurihara J, Hiraide T, Takahashi K, Kato H, Katayama Y. Effects of FK506 on the translocation of protein kinase C and CaM kinase II in the gerbil hippocampal CA1 neurons. Neurol Res 2003;25:522-7. (Pubitemid 36870536)
22. Katsura K, Takahashi K, Asoh S, Watanabe M, Sakurazawa M, Ohsawa I, et al. Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat. J Neurochem 2008;106:258-70. (Pubitemid 351840209)
23. Kuroda S, Janelidze S, Siesjo BK. The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats. Brain Res 1999;835:148-53. (Pubitemid 29343776)
24. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, et al. BDNF genemodified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004;9:189-97. (Pubitemid 38256545)
25. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008;131:616-29. (Pubitemid 351294711)
26. Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-15. (Pubitemid 121001714)
27. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006;129:2734-45. (Pubitemid 44522106)
28. Lyden PD, Jackson-Friedman C, Shin C, Hassid S. Synergistic combinatorial stroke therapy: a quantal bioassay of a GABA agonist and a glutamate antagonist. Exp Neurol 2000;163:477-89. (Pubitemid 30399098)
29. Ministry of Health, Labour and Welfare, Japan. Health and sanitation. In: Ministry of Health, Labour and Welfare, Japan, editor. Statistical abstract on health and welfare in Japan. Tokyo: Health and Welfare Statistics Association of Japan; 2002. p. 69-130.
30. Merry DE, Korsmeyer SJ. Bcl-2 gene family in the nervous system. Annu Rev Neurosci 1997;20:245-67.
31. Morita M, Imai H, Liu Y, Xu X, Sadamatsu M, Nakagami R, et al. FK506-protective effects against trimethyltin neurotoxicity in rats: hippocampal expression analyses reveal the involvement of periarterial osteopontin. Neuroscience 2008;153:1135-45.
32. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007;110:3499-506. (Pubitemid 350159613)
33. Nito C, Kamiya T, Ueda M, Arii T, Katayama Y. Mild hypothermia enhances the neuroprotective effects of FK506 and expands its therapeutic window following transient focal ischemia in rats. Brain Res 2004;1008:179-85. (Pubitemid 38624047)
34. Noto T, Furuichi Y, Ishiye M, Matsuoka N, Aramori I, Mutoh S, et al. Tacrolimus (FK506) limits accumulation of granulocytes and platelets and protects against brain damage after transient focal cerebral ischemia in rat. Biol Pharm Bull 2007;30:313-7.
35. Okubo S, IgarashiH, Kanamatsu T,Hasegawa D,OrimaH, Katayama Y. FK-506 extended the therapeutic timewindowfor thrombolysiswithout increasing the risk of hemorrhagic transformation in an embolic rat stroke model. Brain Res 2007;1143:221-7. (Pubitemid 46440820)
36. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-71. (Pubitemid 41021278)
37. Squadrito F, Altavilla D, Squadrito G, Saitta A, Deodato B, Arlotta M, et al. Tacrolimus limits polymorphonuclear leucocyte accumulation and protects against myocardial ischaemia-reperfusion injury. J Mol Cell Cardiol 2000;32:429-40.
38. Sharkey J, Butcher SP. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 1994;371:336-9. (Pubitemid 24300615)
39. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990;10:290-3. (Pubitemid 20096202)
40. Tolar J, Villeneuve P, Keating A. Mesenchymal stromal cells for graft-versus-host disease. Hum Gene Ther 2011;22:257-62.
41. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Dose-dependent, protective effect of FK506 against white matter changes in the rat brain after chronic cerebral ischemia. Brain Res 1998;792:105-13. (Pubitemid 28261174)
42. Wang Q, Tang XN, Yenari MA. The inflammatory response in stroke. J Neuroimmunol 2007;184:53-68. (Pubitemid 46365991)
43. Warlow CP. Epidemiology of stroke. Lancet 1998;352(Suppl 3):SIII1-4.
44. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 2000;61:364-70. (Pubitemid 30620221)
45. Yagita Y, Kitagawa K, Matsushita K, Taguchi A, Mabuchi T, Ohtsuki T, et al. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci 1996;59:1643-50. (Pubitemid 26358294)
46. Yu J, Zheng C, Ren X, Li J, Zhang L, Liang L, et al. Intravenous administration of bone marrow mesenchymal stem cells benefits experimental autoimmune myasthenia gravis mice through an immunomodulatory action. Scand J Immunol 2010;72: 242-9.
47. Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB, et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005;195:16-26. (Pubitemid 41116810)